{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:56:41Z","timestamp":1781225801533,"version":"3.54.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10585-0","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:34:38Z","timestamp":1764552878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heart failure with preserved ejection fraction, from pathophysiology to technology tools aim to improve patients\u2019 management"],"prefix":"10.1007","volume":"31","author":[{"given":"Andrea","family":"Pozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Spoladore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"D\u2019Amario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"10","key":"10585_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay SM, Roger VL, Redfield MM (2017) Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 14(10):591\u2013602","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10585_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/heartjnl-2015-307787","volume":"102","author":"C Franssen","year":"2016","unstructured":"Franssen C, Chen S, Hamdani N, Paulus WJ (2016) From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress. Heart 102(4):320\u2013330","journal-title":"Heart"},{"issue":"4","key":"10585_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263\u2013271","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10585_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11897-017-0332-1","volume":"14","author":"A Iorio","year":"2017","unstructured":"Iorio A, Pozzi A, Senni M (2017) Addressing the heterogeneity of heart failure in future randomized trials. Curr Heart Fail Rep 14(3):197\u2013202","journal-title":"Curr Heart Fail Rep"},{"issue":"5","key":"10585_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051375","volume":"13","author":"F Luc\u00e0","year":"2024","unstructured":"Luc\u00e0 F, Oliva F, Abrignani MG, Di Fusco SA, Gori M, Giubilato S et al (2024) Heart failure with preserved ejection fraction: how to deal with this chameleon. J Clin Med 13(5):1375","journal-title":"J Clin Med"},{"issue":"3","key":"10585_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ejhf.1614","volume":"22","author":"A Barandiar\u00e1n Aizpurua","year":"2020","unstructured":"Barandiar\u00e1n Aizpurua A, Sanders-van Wijk S, Brunner-La Rocca HP, Henkens M, Heymans S, Beussink-Nelson L et al (2020) Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction. Eur J Heart Fail 22(3):413\u2013421","journal-title":"Eur J Heart Fail"},{"issue":"40","key":"10585_CR7","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","volume":"40","author":"B Pieske","year":"2019","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA, Fraser AG, Anker SD, Donal E et al (2019) How to diagnose heart failure with preserved ejection fraction: the HFA\u2013PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 40(40):3297\u2013317","journal-title":"Eur Heart J"},{"issue":"20","key":"10585_CR8","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.118.038594","volume":"139","author":"N Sepehrvand","year":"2019","unstructured":"Sepehrvand N, Alemayehu W, Dyck GJB, Dyck JRB, Anderson T, Howlett J et al (2019) External validation of the H\u2009<\u2009sub\u2009>\u20092\u2009F-PEF model in diagnosing patients with heart failure and preserved ejection fraction. Circulation 139(20):2377\u20132379","journal-title":"Circulation"},{"issue":"3","key":"10585_CR9","first-page":"169","volume":"9","author":"S Oghina","year":"2021","unstructured":"Oghina S, Bougouin W, B\u00e9zard M, Kharoubi M, Komajda M, Cohen-Solal A et al (2021) The impact of patients with cardiac amyloidosis in HFpEF trials. JACC: Heart Failure 9(3):169\u201378","journal-title":"JACC: Heart Failure"},{"issue":"36","key":"10585_CR10","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 42(36):3599\u20133726","journal-title":"Eur Heart J"},{"issue":"18","key":"10585_CR11","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 145(18):e895\u2013e1032","journal-title":"Circulation"},{"issue":"6","key":"10585_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/01.CIR.0000155257.33485.6D","volume":"111","author":"A Borb\u00e9ly","year":"2005","unstructured":"Borb\u00e9ly A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ et al (2005) Cardiomyocyte stiffness in diastolic heart failure. Circulation 111(6):774\u2013781","journal-title":"Circulation"},{"issue":"16","key":"10585_CR13","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","volume":"113","author":"L van Heerebeek","year":"2006","unstructured":"van Heerebeek L, Borb\u00e9ly A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ et al (2006) Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113(16):1966\u20131973","journal-title":"Circulation"},{"issue":"1","key":"10585_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","volume":"4","author":"D Westermann","year":"2011","unstructured":"Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F et al (2011) Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4(1):44\u201352","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10585_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/CIRCULATIONAHA.109.850677","volume":"121","author":"RR Chaturvedi","year":"2010","unstructured":"Chaturvedi RR, Herron T, Simmons R, Shore D, Kumar P, Sethia B et al (2010) Passive stiffness of myocardium from congenital heart disease and implications for diastole. Circulation 121(8):979\u2013988","journal-title":"Circulation"},{"issue":"5","key":"10585_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00395-009-0014-6","volume":"104","author":"D Westermann","year":"2009","unstructured":"Westermann D, Riad A, Richter U, J\u00e4ger S, Savvatis K, Schuchardt M et al (2009) Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure. Basic Res Cardiol 104(5):499\u2013509","journal-title":"Basic Res Cardiol"},{"issue":"10","key":"10585_CR17","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","volume":"128","author":"WJ Paulus","year":"2021","unstructured":"Paulus WJ, Zile MR (2021) From systemic inflammation to myocardial fibrosis. Circ Res 128(10):1451\u20131467","journal-title":"Circ Res"},{"issue":"7","key":"10585_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/CIRCRESAHA.109.198465","volume":"105","author":"C Hidalgo","year":"2009","unstructured":"Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M et al (2009) PKC phosphorylation of titin\u2019s PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res 105(7):631\u2013638","journal-title":"Circ Res"},{"issue":"1","key":"10585_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/CIRCRESAHA.108.184408","volume":"104","author":"M Kr\u00fcger","year":"2009","unstructured":"Kr\u00fcger M, K\u00f6tter S, Gr\u00fctzner A, Lang P, Andresen C, Redfield MM et al (2009) Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the Titin springs. Circ Res 104(1):87\u201394","journal-title":"Circ Res"},{"issue":"3","key":"10585_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1085\/jgp.200409177","volume":"125","author":"N Fukuda","year":"2005","unstructured":"Fukuda N, Wu Y, Nair P, Granzier HL (2005) Phosphorylation of Titin modulates passive stiffness of cardiac muscle in a Titin isoform-dependent manner. J Gen Physiol 125(3):257\u2013271","journal-title":"J Gen Physiol"},{"issue":"2","key":"10585_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/cvr\/cvab008","volume":"118","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen J, Fontes SK, Bautista EN, Cheng Z (2022) Physiological and pathological roles of protein kinase A in the heart. Cardiovasc Res 118(2):386\u2013398","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10585_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","volume":"117","author":"L van Heerebeek","year":"2008","unstructured":"van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K et al (2008) Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117(1):43\u201351","journal-title":"Circulation"},{"issue":"4","key":"10585_CR23","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/ehf2.14626","volume":"11","author":"D D\u2019Amario","year":"2024","unstructured":"D\u2019Amario D, Laborante R, Bianchini E, Ciliberti G, Paglianiti DA, Galli M et al (2024) Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysis. ESC Heart Fail 11(4):2063\u201375","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10585_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jacc.2012.02.055","volume":"60","author":"MJ Haykowsky","year":"2012","unstructured":"Haykowsky MJ, Brubaker PH, Stewart KP, Morgan TM, Eggebeen J, Kitzman DW (2012) Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol 60(2):120\u2013128","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10585_CR25","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","volume":"57","author":"M Kasner","year":"2011","unstructured":"Kasner M, Westermann D, Lopez B, Gaub R, Escher F, K\u00fchl U et al (2011) Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol 57(8):977\u201385","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10585_CR26","doi-asserted-by":"publisher","first-page":"C1893","DOI":"10.1152\/ajpcell.01043.2024","volume":"328","author":"S Chakraborty","year":"2025","unstructured":"Chakraborty S, Dutta A, Roy A, Joshi A, Basak T (2025) The theatrics of collagens in the myocardium: the supreme architect of the fibrotic heart. Am J Physiol Cell Physiol 328(6):C1893\u2013c920","journal-title":"Am J Physiol Cell Physiol"},{"issue":"18","key":"10585_CR27","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.jacc.2011.06.058","volume":"58","author":"A Gonz\u00e1lez","year":"2011","unstructured":"Gonz\u00e1lez A, Ravassa S, Beaumont J, L\u00f3pez B, D\u00edez J (2011) New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 58(18):1833\u20131843","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10585_CR28","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","volume":"118","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ (2023) Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res 118(18):3434\u20133450","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10585_CR29","doi-asserted-by":"publisher","first-page":"102483","DOI":"10.1016\/j.jchf.2025.02.029","volume":"13","author":"FR Giugni","year":"2025","unstructured":"Giugni FR, Yang Y, Claggett B, Lamberson V, Solomon SD, Lutsey PL et al (2025) Differential associations of Cardiac, Pulmonary, Arterial, and muscle physiological parameters and biomarkers with the incidence of HFpEF and HFrEF. JACC Heart Fail 13(8):102483","journal-title":"JACC Heart Fail"},{"issue":"4 Pt 1","key":"10585_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/01.CIR.56.4.605","volume":"56","author":"J Feldschuh","year":"1977","unstructured":"Feldschuh J, Enson Y (1977) Prediction of the normal blood volume. Relation of blood volume to body habitus. Circulation 56(4 Pt 1):605\u2013612","journal-title":"Circulation"},{"issue":"1","key":"10585_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.15420\/cfr.2018.31.1","volume":"5","author":"JH Morris","year":"2019","unstructured":"Morris JH, Chen L (2019) Exercise training and heart failure: a review of the literature. Card Fail Rev 5(1):57\u201361","journal-title":"Card Fail Rev"},{"issue":"19","key":"10585_CR32","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52(19):1527\u20131539","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10585_CR33","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, Ho JE (2023) Heart failure with preserved ejection fraction. J Am Coll Cardiol 81(18):1810\u20131834","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10585_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12265-017-9756-y","volume":"10","author":"SJ Shah","year":"2017","unstructured":"Shah SJ (2017) Precision medicine for heart failure with preserved ejection fraction: an overview. J Cardiovasc Transl Res 10(3):233\u2013244","journal-title":"J Cardiovasc Transl Res"},{"issue":"7","key":"10585_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jchf.2015.02.008","volume":"3","author":"DK Gupta","year":"2015","unstructured":"Gupta DK, de Lemos JA, Ayers CR, Berry JD, Wang TJ (2015) Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study. JACC Heart Fail 3(7):513\u20139","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10585_CR36","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1210\/jc.2011-1182","volume":"96","author":"AM Khan","year":"2011","unstructured":"Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, McCabe EL et al (2011) Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab 96(10):3242\u20139","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10585_CR37","doi-asserted-by":"publisher","first-page":"e004750","DOI":"10.1161\/CIRCHEARTFAILURE.117.004750","volume":"11","author":"AS Eisman","year":"2018","unstructured":"Eisman AS, Shah RV, Dhakal BP, Pappagianopoulos PP, Wooster L, Bailey C et al (2018) Pulmonary capillary wedge pressure patterns during exercise predict exercise capacity and incident heart failure. Circ Heart Fail 11(5):e004750","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10585_CR38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","volume":"3","author":"BA Borlaug","year":"2010","unstructured":"Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM (2010) Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 3(5):588\u2013595","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10585_CR39","doi-asserted-by":"crossref","first-page":"e008935","DOI":"10.1161\/CIRCHEARTFAILURE.121.008935","volume":"15","author":"AA van de Bovenkamp","year":"2022","unstructured":"van de Bovenkamp AA, Wijkstra N, Oosterveer FPT, Vonk Noordegraaf A, Bogaard HJ, van Rossum AC et al (2022) The value of passive leg Raise during right heart catheterization in diagnosing heart failure with preserved ejection fraction. Circ Heart Fail 15(4):e008935","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10585_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.chest.2020.08.019","volume":"159","author":"M D\u2019Alto","year":"2021","unstructured":"D\u2019Alto M, Badesch D, Bossone E, Borlaug BA, Brittain E, Humbert M et al (2021) A fluid challenge test for the diagnosis of occult heart failure. Chest 159(2):791\u20137","journal-title":"Chest"},{"issue":"9","key":"10585_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/CIRCULATIONAHA.116.024822","volume":"135","author":"M Obokata","year":"2017","unstructured":"Obokata M, Kane GC, Reddy YN, Olson TP, Melenovsky V, Borlaug BA (2017) Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study. Circulation 135(9):825\u2013838","journal-title":"Circulation"},{"issue":"12","key":"10585_CR42","first-page":"e012020","volume":"17","author":"M Fudim","year":"2024","unstructured":"Fudim M, Kittipibul V, Swavely A, Gray A, Mikitka J, Young E et al (2024) Discrepancy in the diagnosis of heart failure with preserved ejection fraction between supine versus upright exercise hemodynamic testing. Circulation: Heart Fail 17(12):e012020","journal-title":"Circulation: Heart Fail"},{"issue":"15","key":"10585_CR43","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B et al (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370(15):1383\u20131392","journal-title":"N Engl J Med"},{"issue":"17","key":"10585_CR44","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP et al (2019) Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med 381(17):1609\u20131620","journal-title":"N Engl J Med"},{"issue":"23","key":"10585_CR45","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359(23):2456\u20132467","journal-title":"N Engl J Med"},{"issue":"9386","key":"10585_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ et al (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial. Lancet 362(9386):777\u201381","journal-title":"Lancet"},{"issue":"11","key":"10585_CR47","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007\u20131016","journal-title":"N Engl J Med"},{"issue":"1","key":"10585_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa2409134","volume":"392","author":"M Fontana","year":"2025","unstructured":"Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B et al (2025) Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. N Engl J Med 392(1):33\u201344","journal-title":"N Engl J Med"},{"issue":"31","key":"10585_CR49","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehad347","volume":"44","author":"A Ioannou","year":"2023","unstructured":"Ioannou A, Massa P, Patel RK, Razvi Y, Porcari A, Rauf MU et al (2023) Conventional heart failure therapy in cardiac ATTR amyloidosis. Eur Heart J 44(31):2893\u2013907","journal-title":"Eur Heart J"},{"issue":"16","key":"10585_CR50","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385(16):1451\u20131461","journal-title":"N Engl J Med"},{"issue":"7","key":"10585_CR51","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/ejhf.2249","volume":"23","author":"SD Solomon","year":"2021","unstructured":"Solomon SD, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN et al (2021) Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial. Eur J Heart Fail 23(7):1217\u201325","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10585_CR52","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.7150\/thno.54498","volume":"11","author":"Z Liu","year":"2021","unstructured":"Liu Z, Ma X, Ilyas I, Zheng X, Luo S, Little PJ et al (2021) Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics. Theranostics 11(9):4502\u20134515","journal-title":"Theranostics"},{"issue":"6","key":"10585_CR53","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.ekir.2024.02.1435","volume":"9","author":"SA Lee","year":"2024","unstructured":"Lee SA, Riella LV (2024) Narrative review of immunomodulatory and anti-inflammatory effects of Sodium-Glucose cotransporter 2 inhibitors: unveiling novel therapeutic frontiers. Kidney Int Rep 9(6):1601\u20131613","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10585_CR54","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12933-025-02767-9","volume":"24","author":"F Cinti","year":"2025","unstructured":"Cinti F, Laborante R, Cappannoli L, Morciano C, Gugliandolo S, Pontecorvi A et al (2025) The effects of SGLT2i on cardiac metabolism in patients with hfpef: fact or fiction? Cardiovasc Diabetol 24(1):208","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10585_CR55","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12933-025-02912-4","volume":"24","author":"F Cinti","year":"2025","unstructured":"Cinti F, Morciano C, Guarneri A, Cappannoli L, Sorice G, Gugliandolo S et al (2025) Coronary flow reserve increase after 4-year Dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study. Cardiovasc Diabetol 24(1):351","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10585_CR56","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Abildstr\u00f8m SZ, Borlaug BA, Butler J, Rasmussen S, Davies M et al (2023) Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med 389(12):1069\u20131084","journal-title":"N Engl J Med"},{"issue":"5","key":"10585_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","volume":"392","author":"M Packer","year":"2025","unstructured":"Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V et al (2025) Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med 392(5):427\u2013437","journal-title":"N Engl J Med"},{"key":"10585_CR58","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger N, Schneeweiss S, Fuse K, Matseyko S, Sreedhara SK, Hahn G et al (2025) Semaglutide and Tirzepatide in patients with heart failure with preserved ejection fraction. JAMA","DOI":"10.1001\/jama.2025.14092"},{"key":"10585_CR59","doi-asserted-by":"crossref","unstructured":"Galli M, Benenati S, Laudani C, Simeone B, Sarto G, Ortega-Paz L et al (2025) Cardiovascular effects and tolerability of GLP-1 receptor agonists: A systematic review and Meta-Analysis of 99,592 patients. J Am Coll Cardiol","DOI":"10.1016\/j.jacc.2025.08.027"},{"issue":"16","key":"10585_CR60","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","volume":"391","author":"SD Solomon","year":"2024","unstructured":"Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS et al (2024) Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 391(16):1475\u20131485","journal-title":"N Engl J Med"},{"issue":"24","key":"10585_CR61","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P et al (2021) Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med 385(24):2252\u20132263","journal-title":"N Engl J Med"},{"issue":"4","key":"10585_CR62","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/joim.13709","volume":"294","author":"A Edsj\u00f6","year":"2023","unstructured":"Edsj\u00f6 A, Holmquist L, Geoerger B, Nowak F, Gomon G, Alix-Panabi\u00e8res C et al (2023) Precision cancer medicine: concepts, current practice, and future developments. J Intern Med 294(4):455\u201381","journal-title":"J Intern Med"},{"issue":"1","key":"10585_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-024-01760-0","volume":"9","author":"X-P Duan","year":"2024","unstructured":"Duan X-P, Qin B-D, Jiao X-D, Liu K, Wang Z, Zang Y-S (2024) New clinical trial design in precision medicine: discovery, development and direction. Signal Transduct Target Therapy 9(1):57","journal-title":"Signal Transduct Target Therapy"},{"key":"10585_CR64","doi-asserted-by":"crossref","unstructured":"K\u00f6nig IR, Fuchs O, Hansen G, von Mutius E, Kopp MV (2017) What is precision medicine? Eur Respir J 50(4)","DOI":"10.1183\/13993003.00391-2017"},{"issue":"30","key":"10585_CR65","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1200\/JCO.21.02285","volume":"40","author":"BP Hobbs","year":"2022","unstructured":"Hobbs BP, Pestana RC, Zabor EC, Kaizer AM, Hong DS (2022) Basket trials: review of current practice and innovations for future trials. J Clin Oncol 40(30):3520\u20133528","journal-title":"J Clin Oncol"},{"issue":"2","key":"10585_CR66","first-page":"125","volume":"70","author":"JJH Park","year":"2020","unstructured":"Park JJH, Hsu G, Siden EG, Thorlund K, Mills EJ (2020) An overview of precision oncology basket and umbrella trials for clinicians. CA Cancer J Clin 70(2):125\u2013137","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10585_CR67","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.euf.2023.10.016","volume":"9","author":"NW Clarke","year":"2023","unstructured":"Clarke NW, James ND (2023) How to compose platform trials. Eur Urol Focus 9(5):715\u2013718","journal-title":"Eur Urol Focus"},{"key":"10585_CR68","first-page":"102384","volume":"67","author":"F Koenig","year":"2024","unstructured":"Koenig F, Spiertz C, Millar D, Rodr\u00edguez-Navarro S, Mach\u00edn N, Van Dessel A et al (2024) Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL. eClin Med 67:102384","journal-title":"eClin Med"},{"issue":"12","key":"10585_CR69","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.echo.2018.07.013","volume":"31","author":"M Tabassian","year":"2018","unstructured":"Tabassian M, Sunderji I, Erdei T, Sanchez-Martinez S, Degiovanni A, Marino P et al (2018) Diagnosis of heart failure with preserved ejection fraction: machine learning of Spatiotemporal variations in left ventricular deformation. J Am Soc Echocardiogr 31(12):1272\u201384e9","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"10585_CR70","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ejhf.1240","volume":"20","author":"RT Campbell","year":"2018","unstructured":"Campbell RT, Petrie MC, Jackson CE, Jhund PS, Wright A, Gardner RS et al (2018) Which patients with heart failure should receive specialist palliative care? Eur J Heart Fail 20(9):1338\u201347","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10585_CR71","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","volume":"131","author":"SJ Shah","year":"2015","unstructured":"Shah SJ, Katz DH, Selvaraj S, Burke MA, Yancy CW, Gheorghiade M et al (2015) Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 131(3):269\u2013279","journal-title":"Circulation"},{"issue":"1","key":"10585_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jchf.2019.06.013","volume":"8","author":"S Angraal","year":"2020","unstructured":"Angraal S, Mortazavi BJ, Gupta A, Khera R, Ahmad T, Desai NR et al (2020) Machine learning prediction of mortality and hospitalization in heart failure with preserved ejection fraction. JACC Heart Fail 8(1):12\u201321","journal-title":"JACC Heart Fail"},{"key":"10585_CR73","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.15420\/cfr.2019.17","volume":"6","author":"D D\u2019Amario","year":"2020","unstructured":"D\u2019Amario D, Canonico F, Rodolico D, Borovac JA, Vergallo R, Montone RA et al (2020) Telemedicine, artificial intelligence and humanisation of clinical pathways in heart failure management: back to the future and beyond. Card Fail Rev 6:e16","journal-title":"Card Fail Rev"},{"key":"10585_CR74","doi-asserted-by":"crossref","unstructured":"Tedeschi A, Palazzini M, Trimarchi G, Conti N, Di Spigno F, Gentile P et al (2024) Heart failure management through telehealth: expanding care and connecting hearts. J Clin Med 13(9)","DOI":"10.3390\/jcm13092592"},{"issue":"12","key":"10585_CR75","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1002\/ejhf.2655","volume":"24","author":"A Zito","year":"2022","unstructured":"Zito A, Princi G, Romiti GF, Galli M, Basili S, Liuzzo G et al (2022) Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis. Eur J Heart Fail 24(12):2333\u201341","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10585_CR76","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/HYPERTENSIONAHA.121.18153","volume":"78","author":"D Clark","year":"2021","unstructured":"Clark D, Woods J 3rd, Zhang Y, Chandra S, Summers RL, Jones DW (2021) Home blood pressure telemonitoring with remote hypertension management in a rural and low-income population. Hypertension 78(6):1927\u20139","journal-title":"Hypertension"},{"issue":"7","key":"10585_CR77","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/jhh.2016.99","volume":"31","author":"Y Duan","year":"2017","unstructured":"Duan Y, Xie Z, Dong F, Wu Z, Lin Z, Sun N et al (2017) Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies. J Hum Hypertens 31(7):427\u2013437","journal-title":"J Hum Hypertens"},{"issue":"9","key":"10585_CR78","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jamainternmed.2022.2947","volume":"182","author":"MJ Crowley","year":"2022","unstructured":"Crowley MJ, Tarkington PE, Bosworth HB, Jeffreys AS, Coffman CJ, Maciejewski ML et al (2022) Effect of a comprehensive telehealth intervention vs telemonitoring and care coordination in patients with persistently poor type 2 diabetes control: a randomized clinical trial. JAMA Intern Med 182(9):943\u2013952","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10585_CR79","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1111\/dom.15870","volume":"26","author":"T Saetang","year":"2024","unstructured":"Saetang T, Greeviroj P, Thavaraputta S, Santisitthanon P, Houngngam N, Laichuthai N (2024) The effectiveness of telemonitoring and integrated personalized diabetes management in people with insulin-treated type 2 diabetes mellitus. Diabetes Obes Metab 26(11):5233\u20135238","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10585_CR80","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.chest.2022.07.032","volume":"162","author":"K Murase","year":"2022","unstructured":"Murase K, Minami T, Hamada S, Gozal D, Takahashi N, Nakatsuka Y et al (2022) Multimodal telemonitoring for weight reduction in patients with sleep apnea: a randomized controlled trial. Chest 162(6):1373\u201383","journal-title":"Chest"},{"key":"10585_CR81","doi-asserted-by":"crossref","unstructured":"Eid NMS, Al-Ofi EA, Enani S, Mosli RH, Saqr RR, Qutah KM et al (2024) The impact of telemonitoring and telehealth coaching on general nutrition knowledge in overweight and obese individuals: A pilot randomized controlled trial. Med Sci (Basel) 12(4)","DOI":"10.3390\/medsci12040068"},{"issue":"6","key":"10585_CR82","doi-asserted-by":"publisher","first-page":"e059945","DOI":"10.1136\/bmjopen-2021-059945","volume":"12","author":"V Antoniou","year":"2022","unstructured":"Antoniou V, Xanthopoulos A, Giamouzis G, Davos C, Batalik L, Stavrou V et al (2022) Efficacy, efficiency and safety of a cardiac telerehabilitation programme using wearable sensors in patients with coronary heart disease: the TELEWEAR-CR study protocol. BMJ Open 12(6):e059945","journal-title":"BMJ Open"},{"issue":"4","key":"10585_CR83","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/2047487319892201","volume":"27","author":"A Avila","year":"2020","unstructured":"Avila A, Claes J, Buys R, Azzawi M, Vanhees L, Cornelissen V (2020) Home-based exercise with telemonitoring guidance in patients with coronary artery disease: does it improve long-term physical fitness? Eur J Prev Cardiol 27(4):367\u2013377","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"10585_CR84","first-page":"e012754","volume":"18","author":"MR Zile","year":"2025","unstructured":"Zile MR, Abraham WT, Stevenson LW, Costanzo MR, Angermann CE, Mehra MR et al (2025) Relationship between Remote, ambulatory pulmonary artery Pressures, and All-Cause mortality in patients with chronic heart failure. Circulation: Heart Fail 18(6):e012754","journal-title":"Circulation: Heart Fail"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10585-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10585-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10585-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:02:53Z","timestamp":1765605773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10585-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10585"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10585-0","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}